Fig. 1From: Therapy resistant urticaria as a long-term symptom of an incomplete Schnitzler syndromeFigurative representation of recorded burden of disease, treatments, and diagnosis over the time. *initially Anakinra, then (04/2022) Canakinumab, **Myasthenia Gravis treatment. Yellow arrows indicate Omalizumab therapy, dashed line indicates period without recorded hospital visit. ACE; Angiotensin-converting enzyme, AH; Antihistamines, Gluc.; GlucocorticoBack to article page